Wednesday, August 5, 2026

Stock Market on High Alert as they Await Federal Reserve Chairman Jerome Powell’s Semi-Annual Report

Congressional testimony from Federal Reserve Chairman Jerome...

North Korean Troops in Russia’s Underground Tunnel Construction

There are speculations that North Korean soldiers will be mobilized for Russia's tunnel construction for the attack on Ukraine.

Unveiling History: First Release of North-South Nuclear Talks Documents from 1990s

South Korea discloses 3,836 pages of nuclear negotiation minutes, revealing intense debates and failed denuclearization efforts from the 1990s.

Health

5 Key Research Findings on Dr. Noon CVD: A Game-Changer for Cardiovascular Disease Prevention

Mediwhale presented five abstracts on its AI-based cardiovascular risk assessment solution, Dr. Noon CVD, at the ASPC conference.

“Improved Survival Rates”… Carboplatin Combination Therapy Shows Benefit in Triple-Negative Breast Cancer

Adding carboplatin to chemotherapy for operable triple-negative breast cancer reduces recurrence risk and improves survival, study finds.

Inventage Lab Selected for Global TIPS Program, Accelerating Late-Stage Development of Addiction Treatment

Inventis Lab's long-acting drug IVL3004 for addiction treatment has been selected for the Global TIPS research project by the Ministry of SMEs.

Bukwang Pharm Signs Export Agreement With Thailand’s Pacific Healthcare for Dexid

Bukwang Pharmaceutical signs exclusive export contract for diabetes treatment 'Dexide' with Pacific Healthcare in Thailand.

Huawei Unveils OpenPangu 2.0 Pro: Is This the Future of AI with 505 Billion Parameters?

Huawei accelerates its AI ecosystem expansion by revealing the source of its massive AI model with over 500 billion parameters.
Latest

Patches, Implants, and Oral Films… The Drug-Delivery Format Battle After Oral Wegovy

Oral Wegovy's launch is transforming obesity treatment, focusing on user-friendly delivery methods and enhancing patient adherence.

Unlocking Convenience: Rolvedon’s Same-Day Chemotherapy Solution for Neutropenia Revealed

Hanmi Pharmaceutical's Rolvedon shows potential for same-day chemotherapy administration, improving patient convenience and market competitiveness.

How MiniRin and Nokdernah Are Revolutionizing Nocturia Care for Seniors: A Comprehensive Guide

Hanmi Pharmaceutical and Ferring Korea partner to distribute Minirin and Nocdurna for nocturia treatment, enhancing patient access.

Celltrion’s Eydenzelt: How Strategic Patent Agreements Enable U.S. and European Market Entry in 2026

Celltrion's Eydenzelt secures global distribution via strategic patent agreements, aiming for swift market entry in the U.S. and Europe.

Is RPG-102 the Future of Obesity Treatment? Discover the Breakthrough Oral Solution!

ProGen and Rani Therapeutics initiate a Phase 1 trial for RPG-102, an oral obesity treatment, aiming for effective weight loss with weekly dosing.

How CLOSER AI is Revolutionizing Depression Diagnosis: Insights from KAIST’s Latest Research

KAIST's AI tool CLOSER detects depression symptoms through daily behavior analysis, paving the way for personalized treatment options.

Revolutionizing Mental Health: How AI-Powered Legion Health is Redefining Patient Care

ZD Ventures invests in Legion Health, a telemedicine clinic, leveraging AI to improve mental health care efficiency in the U.S.

HK inno.N’s New Drug K-CAB Applies for U.S. FDA Approval: How Innovative Is the P-CAB Therapy?

HK inno.N's K-Cap for GERD has entered the U.S. approval process, showing superior results in clinical trials over existing treatments.

How Neurophet AQUA is Transforming Dementia Diagnosis in South Korea: Key MOU Insights

Neurophet partners with Eisai Korea to enhance dementia screening and diagnostics using AI-based software, Neurophet AQUA.

Revolutionizing Kidney Stone Surgery: Roen Surgical’s AI Robot Zamenix Launches in Indonesia

Roen Surgical exports AI-powered kidney stone surgery robot Zamenix to Indonesia, enhancing surgical precision and safety in healthcare.

CES 2026: Medicube’s Beauty Tech Innovations Captivate 1,600 Visitors – What You Need to Know

APR Co Ltd successfully showcased its Medicube beauty tech at CES 2026, attracting 1,600 visitors and planning global expansion.

HLB’s Liragratinib: A Game-Changer in Cholangiocarcinoma Treatment Revealed at ASCO GI 2026!

HLB's lirafugratinib shows promise as a precision oncology drug, targeting FGFR2 in cancer treatment. FDA application expected soon.

SK Biofarm, FDA Approved Radioactive Method: Will it be a Revolutionary Cancer Cure with SLK 33501?

SK Biopharmaceuticals gains FDA approval for Phase 1 trials of radiopharmaceuticals SKL35501 and SKL35502, advancing cancer treatment.

The Easiest Way To Lose Investor Trust? Just Steal $6.7 Billion! BMS Masterclass In Bad Business

Bristol Myers Squibb faces a $6.7B lawsuit over alleged delays in drug approvals affecting former Celgene shareholders' payouts.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.